Susan Furth, MD, PhD, chief scientific officer of Children’s Hospital of Philadelphia Research Institute, showcases the ingenuity of scientists and staff who make achievements in pediatric science possible.
All content for BENCH to BEDSIDE is the property of Dr. Susan Furth and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Susan Furth, MD, PhD, chief scientific officer of Children’s Hospital of Philadelphia Research Institute, showcases the ingenuity of scientists and staff who make achievements in pediatric science possible.
New Frontiers: Precision Medicine a ‘Unique Signature’ for Pediatric Cancer Patients
BENCH to BEDSIDE
16 minutes 31 seconds
1 year ago
New Frontiers: Precision Medicine a ‘Unique Signature’ for Pediatric Cancer Patients
Precision medicine, also known as personalized medicine, has revolutionized how physicians and scientists treat and study disease. According to Theodore Laetsch, MD, an oncologist at Children’s Hospital of Philadelphia, this ability to track and tailor individual patients’ unique genetic signatures has the most transformative potential in pediatric cancer. In this episode of Bench to Bedside, Dr. Laetsch shares how his new Frontier Program, the Center for Precision Medicine for High-risk Pediatric Cancer, harnesses advanced technologies and a growing multi omics database to optimize outcomes for childhood cancer patients.
BENCH to BEDSIDE
Susan Furth, MD, PhD, chief scientific officer of Children’s Hospital of Philadelphia Research Institute, showcases the ingenuity of scientists and staff who make achievements in pediatric science possible.
